N | 322 |
FH genotype | |
Monogenic FH, n (%) | 248 (77.0) |
LDLR, n (%) | 222 (89.5) |
LDLR defective, n (%) | 137 (61.7) |
LDLR null, n (%) | 85 (38.3) |
ApoB, n (%) | 19 (7.7) |
PCSK9, n (%) | 3 (1.2) |
ApoE, n (%) | 4 (1.6) |
Polygenic FH, n (%) | 74 (23.0) |
Monogenic FH phenotype | |
Heterozygous, n (%) | 266 (100) |
Vascular profile | |
Subclinical atherosclerosis, n (%) | 198 (61.5) |
CAC > 0, n (%) | 148 (74.7) |
Peripheral plaque, n (%) | 185 (93.4) |
CAC + Peripheral plaque, n (%) | 73 (36.9) |